At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...